Get the Uncensored News You Want!

(WATCH) Africa’s First COVID-19 Jab Manufacturing Plant Risks Shutting Down After Receiving Not a Single Order

Share on facebook
Share on twitter
Share on telegram
Share on pinterest
Share on whatsapp
Share on email

Africa’s first COVID-19 ‘vaccine’ manufacturing plant risks shutting down after receiving not a single order.

That’s fantastic news.


“South Africa’s Aspen Pharmacare negotiated a licensing deal in November to package and sell Johnson & Johnson’s COVID-19 vaccine and distribute it across Africa,” Reuters reports.

But the plant, touted as a ‘trailblazer’ to inoculate the continent, hasn’t received a single order.

From Reuters:

The World Health Organization (WHO) called the deal a “transformative moment” in the drive towards levelling stark inequalities in access to COVID vaccines.

With only a sixth of adults in Africa fully vaccinated, according to the latest WHO figures from the end of March, Aspen’s agreement to sell an Aspen-branded COVID-19 vaccine, Aspenovax, throughout Africa seemed like a sure bet.

South Africa, which has vaccinated 30% of its population, also looks set to experience a fifth wave of infections.

Africanews added:

Professor Tulio de Oliveira, the director of the Centre for Epidemic Response and Innovation in South Africa, told the BBC that the closure could affect the production of other vaccines that “do not affect the developed world” as well as the preparation for the next pandemic.

It is the aim of the African union that 60% of all vaccines would be produced in Africa, however, with the latest development, Africa is at risk of missing this target.

Maybe Africans don’t want their poison shots.

Haven’t they figured that’s the reason Aspen Pharmacare hasn’t received a single order for the COVID-19 shot?

However, their inflated egos won’t allow them to see this reality.

We Love Trump

More Stories

Leave a Comment

Your email address will not be published. Required fields are marked *